Chybějící geny
DNAJB6
- A co-chaperone of HSP70
- X cause limb girdle muscular dystrophy (LGMD) D1
- No treatments are currently available
- Two isoforms exist, DNAJB6a and DNAJB6b
- Each with distinct localizations in muscle
- Mutations reside in both isoforms
- DNAJB6b is primarily responsible for disease pathogenesis
- DNAJB6 knockout is embryonic lethal
- Isoform-specific knockdown
- Isoform specific knockdown in LGMDD1 - primary myotube cultures from a knockin LGMDD1 mouse model
Selective reduction of DNAJB6b levels in LGMDD1 myotubes
- Corrected much of the proteomic disease signature toward wild type levels
- Wide age range of onset
- May have either a proximal or distal predominant pattern of weakness
- Biopsies demonstrate
- A vacuolar myopathy with aggregates
- Myofibrillar abnormalities involving the Z disc.
- Standard of care is supportive in nature
- Ubiquitously transcribed co-chaperone of HSP70 with a wide array of functions
- Tumor suppressor,
- Prevents aggregation of polyglutamine-containing proteins
- Role in viral replication cycles
- Cause a degenerative disorder of skeletal muscle
- Absence of DNAJB6 manifests differently and is embryonic lethal in mice
- Mutations associated with LGMDD1 are located in regions of DNAJB6 that affect both isoforms
- Zebrafish injected with mutant human DNAJB6b mRNA resulted in myofibrillar abnormalities
- Mutant DNAJB6a mRNA did not
Haploinsufficiency
- May be tolerated
- Associated with a sick sinus syndrome phenotype in mice with no structural cardiac changes
- www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(23)00135-X
- DNAJB6b is Downregulated in Synucleinopathies
- DNAJB6 is highly upregulated in Parkinsonian astrocytes, which might reflect a protective reaction
- The anti-amyloidogenic chaperone DNAJB6
- Loss of expression of the anti-amyloidogenic chaperone DNAJB6
- Upon glutamate treatment, aggregates form in neurons
- Upregulation of DNAJB6 in neurons
- Antagonizes glutamate-induced aggregation
- Knockdown of DNAJB6 in progenitors
- Results in spontaneous polyglutamine aggregation
- Loss of DNAJB6 expression upon differentiation is confirmed in vivo
- Explaining why stem cells are intrinsically protected against amyloidogenesis and protein aggregates are dominantly present in neurons.
- DNAJB6
- Prevent poly-Q dependent protein aggregation and cellular toxicity induced by the mutant huntingtin protein
- PDNAJB6 was found to be significantly upregulated by PCV2 infection
- Heat shock protein Hsp40/DNAJ family
- DNAJB6b promotes cytoplasmic accumulation of the viral primase of CMV
- DNAJB6a enhances nuclear distribution of a herpesvirus primase
- Deficit = výhoda v případě infekce CMV
- DNAJB6 has been shown to interact with keratin
- Aggregation of Abeta42 (a process involved in e.g. Alzheimer's disease) is retarded by DNAJB6 in a concentration-dependent manner
- Dominant mutations in DNAJB6
- Late-onset muscle disease termed limb-girdle muscular dystrophy type D1 (LGMDD1)
- Characterized by protein aggregation and vacuolar myopathology
- en.wikipedia.org/wiki/DNAJB6
- Molecular chaperone for neuronal proteins including huntingtin (PubMed:11896048, 22366786).
- TDP-43 is a client protein of DNAJB6
Dipeptidyl-peptidase–like protein 6 (DPPX) deficit
- DPPX/Kv4.2 potassium channels
- Somatodendritic signal integration
- Attenuation of back-propagation of action potentials
- Kv4 accessory protein DPPX (DPP6) is a critical regulator of membrane excitability in hippocampal CA1 pyramidal neurons.
- X disorders characterized by cognitive inflexibility is described
- Dipeptidyl aminopeptidase-like protein DPPX (DPP6)
- Associates with Kv4 potassium channels
- Increasing surface trafficking and reconstituting native neuronal ISA-like properties
- Dipeptidyl peptidase 10 (DPP10)
- Shares with DPP6 a high amino acid identity
- Lack of enzymatic activity
- Expression predominantly in the brain
- DPP10 is a potent modulator of Kv4 expression and biophysical properties
- May be a critical component of somatodendritic ISA channels in the brain.
- www.semanticscholar.org/paper/Modulation-of-Kv4.2-channel-expression-and-gating-Jerng-Qian/eaa4bf228e629e93be76c8ec7889571a1d0d1036
Antibody–associated encephalitis IgG subclass effects x DPPX
- 9 patients were identified (median age 57 years, range 36–69 years)
- Severe prodromal weight loss or diarrhea followed by cognitive dysfunction (9), memory deficits (5), CNS hyperexcitability
- (8; hyperekplexia, myoclonus, tremor, or seizures)
- Or brainstem or cerebellar dysfunction (7)
- The peak of the disease was reached 8 months (range 1–54 months) after onset
- All patients had both IgG4 and IgG1 DPPX antibodies
- Kv4.2 protein that was reversible on removal of the antibodies
- Reported cases (total 39)
- 67% developed the triad
- Weight loss (median 20 kg; range 8–53 kg)/gastrointestinal symptoms,
- cognitive-mental dysfunction
- CNS hyperexcitability
- 35 patients (8 not treated with immunotherapy)
- 60% had substantial or moderate improvement
- 23% had no improvement (most of them not treated)
- 17% died
- Relapses in 8 of 35 patients (23%) and were responsive to immunotherapy.
- www.ncbi.nlm.nih.gov/pmc/articles/PMC5379928/
- Dipeptidyl-peptidase-like-proteins confer high sensitivity to the scorpion toxin AmmTX3 to Kv4-mediated A-type K+ channels
- www.semanticscholar.org/paper/Dipeptidyl%E2%80%90peptidase%E2%80%90like%E2%80%90proteins-confer-high-to-Maffie-Dvoretskova/30feddcab95f72e815c08bd4abc1f3bef3895720
Kv4.2 KO mice
- Had cognitive deficits in learning and memory (Lugo et al., 2012)
- www.sciencedirect.com/science/article/abs/pii/S0197018621002011
Kv4.2
- Could promote the proliferations of neural stem cells
- Induce the neural stem cells to differentiate into neurons in vitro and in vivo.
- Kv4.2 could up-regulate the expressions of ERK1/2, p-ERK1/2, p-STAT3, NGF, p-TrkA, and BDNF, CAMKII and the concentration of intracellular Ca2+.
- Kv4.2 promoted neurogenesis through ++ERK1/2/STAT3, NGF/TrkA, Ca2+/CAMKII signal pathways++ and rescued the ischemic impairments.
- www.sciencedirect.com/science/article/abs/pii/S0197018621002011
Magnesium Deficiency
- Causes Transcriptional Downregulation of Kir2.1 and Kv4.2 Channels in Cardiomyocytes Resulting in QT Interval Prolongation
- www.jstage.jst.go.jp/article/circj/84/8/84_CJ-20-0310/_pdf
Problematické geny
FOXP2 (Forkhead Box P2)
- Haploinsufficiency of FOXP2 is associated with language and speech disorders.
- This gene plays a crucial role in the development of neural circuits involved in language.
SLC25A13 (Solute Carrier Family 25 Member 13)
- Mutations or deletions in SLC25A13 can lead to citrullinemia
- Autosomal recessive disorder affecting urea cycle metabolism
- Haploinsufficiency may contribute to milder metabolic disturbances.
VLDLR (Very Low-Density Lipoprotein Receptor)
- In lipoprotein metabolism, and haploinsufficiency may impact cholesterol homeostasis.
- Haploinsufficiency of VLDLR has been associated with cerebellar hypoplasia and a milder form of the lissencephaly syndrome.
GLI3 (GLI Family Zinc Finger 3)
- Mutations in GLI3 can cause Greig cephalopolysyndactyly syndrome and Pallister-Hall syndrome.
- Haploinsufficiency of GLI3 is associated with limb abnormalities and craniofacial defects.
CDK13 (Cyclin-Dependent Kinase 13)
- Haploinsufficiency of CDK13 has been associated with developmental disorders and intellectual disabilities.
- Mutations in CDK13 have been associated with developmental disorders and intellectual disabilities.
- Haploinsufficiency of CDK13 may contribute to these conditions.
METTL21A (Methyltransferase Like 21A)
- Information on haploinsufficiency for METTL21A might be limited
- Genes involved in methylation processes can play critical roles in various cellular functions, and disruptions may impact gene expression regulation.
KMT2E (Lysine Methyltransferase 2E)
- Mutations in KMT2E have been associated with intellectual disabilities and developmental disorders.
- Haploinsufficiency of KMT2E may contribute to these conditions.
DLX5 (Distal-Less Homeobox 5)
- DLX5 is involved in embryonic development and mutations can lead to developmental disorders.
- Haploinsufficiency may contribute to craniofacial and limb abnormalities.
NRCAM (Neuronal Cell Adhesion Molecule)
- Mutations or haploinsufficiency of NRCAM have been associated with neurodevelopmental disorders, including autism spectrum disorders.
SP4 (Sp4 Transcription Factor)
- SP4 is a transcription factor involved in neural development, and disruptions may contribute to intellectual disabilities and developmental disorders.
GLI2 (GLI Family Zinc Finger 2)
- Mutations in GLI2 have been associated with various developmental disorders, including holoprosencephaly.
- Haploinsufficiency may contribute to craniofacial and neurological abnormalities.
SEPT9 (Septin 9)
- Mutations in SEPT9 have been associated with hereditary neuralgic amyotrophy, a disorder affecting peripheral nerves.
- Haploinsufficiency may contribute to neurological symptoms.
PRSS12 (Serine Protease 12)
- Information about haploinsufficiency for PRSS12 might be limited,
- serine proteases play crucial roles in various biological processes, and disruptions may affect protein digestion and other functions.
FSCN1 (Fascin Actin-Bundling Protein 1)
- Mutations in FSCN1 have been associated with fascin-related hypertrophic cardiomyopathy.
- Haploinsufficiency may contribute to cardiac abnormalities.
RNF216 (Ring Finger Protein 216)
- Mutations in RNF216 have been associated with intellectual disabilities and developmental disorders.
- Haploinsufficiency of RNF216 may contribute to these conditions.
HMGN2 (High Mobility Group Nucleosomal Binding Domain 2)
- Haploinsufficiency of HMGN2 may impact chromatin structure and gene expression regulation, potentially contributing to developmental or neurological disorders.
THSD7B (Thrombospondin Type 1 Domain Containing 7B)
- Mutations in THSD7B have been associated with developmental disorders, including intellectual disabilities and autism.
- Haploinsufficiency may contribute to these conditions.
AKAP9 (A-Kinase Anchoring Protein 9)
- Mutations in AKAP9 have been associated with intellectual disabilities and developmental disorders.
- Haploinsufficiency may contribute to these conditions.
PRSS16 (Serine Protease 16)
- Specific information about haploinsufficiency for PRSS16 might be limited
- serine proteases play roles in various biological processes, and disruptions may have consequences for protein digestion and other functions.
MEOX1 (Mesenchyme Homeobox 1)
- Mutations in MEOX1 have been associated with Klippel-Feil syndrome, a disorder affecting the development of the spine.
- Haploinsufficiency may contribute to skeletal abnormalities.
CALCR (Calcitonin Receptor)
- The function of CALCR is associated with the regulation of calcium homeostasis
- Haploinsufficiency may impact bone metabolism and calcium regulation.
NOMO1 (NODAL Modulator 1)
- NOMO1 is associated with the regulation of NODAL signaling, which plays a role in embryonic development.
- Haploinsufficiency may contribute to developmental abnormalities.
VIPR2 (Vasoactive Intestinal Peptide Receptor 2)
- Disruptions in VIPR2 may affect vasoactive intestinal peptide signaling, potentially influencing various physiological processes.
- Haploinsufficiency may contribute to imbalances in these processes.
CDK6 (Cyclin-Dependent Kinase 6)
- CDK6 is a cell cycle regulator,
- Haploinsufficiency may impact cell division and proliferation.
Dohledáno via CHAT GPT
FOXP2: The FOXP2 gene in this region is associated with language development. Its deletion could potentially contribute to language and communication challenges.
IMMP2L: This gene is involved in mitochondrial function. Disruptions in IMMP2L could potentially impact cellular energy metabolism.
LHFPL3: Little is known about the exact function of this gene, and its specific role in metabolism may not be well-documented.
CALD1: CALD1 is associated with smooth muscle contraction. Its deletion might impact the function of smooth muscle cells in various organs.
CUL1: CUL1 is involved in protein degradation and may play a role in cellular homeostasis.DLX5: This gene is involved in embryonic development and plays a role in the development of bones and the central nervous system.
DLX6: Like DLX5, DLX6 is also involved in embryonic development and is associated with the development of facial structures and limbs.
IMMP2L (Inner Mitochondrial Membrane Peptidase Subunit 2-Like): This gene is involved in mitochondrial function and may play a role in cellular energy metabolism.
MDFIC (MyoD Family Inhibitor Domain Containing): MDFIC is involved in the regulation of muscle differentiation and may have roles in muscle development.
MEOX1 (Mesenchyme Homeobox 1): MEOX1 is a homeobox-containing gene involved in the regulation of embryonic development and differentiation.
RASA4 (RAS P21 Protein Activator 4): RASA4 is associated with the regulation of Ras signaling, which plays a role in various cellular processes.
PRSS16 (Serine Protease 16): This gene encodes a serine protease and may have roles in protein digestion and other processes.
CALD1 (Caldesmon 1): CALD1 is associated with smooth muscle contraction and may play a role in the regulation of smooth muscle cells in various tissues.
ZNF711 (Zinc Finger Protein 711): ZNF711 is a zinc finger protein involved in transcriptional regulation.
ZNF451 (Zinc Finger Protein 451): This gene encodes a zinc finger protein and may play a role in transcriptional regulation.
SLC25A13 (Solute Carrier Family 25 Member 13): This gene encodes a mitochondrial ornithine transporter and is associated with citrullinemia, a disorder of urea cycle metabolism.
NRCAM (Neuronal Cell Adhesion Molecule): NRCAM is involved in neuronal cell adhesion and may play a role in the development and function of the nervous system.
VIPR2 (Vasoactive Intestinal Peptide Receptor 2): This gene encodes a receptor for vasoactive intestinal peptide (VIP) and may be involved in various physiological processes, including smooth muscle relaxation.
FOXP2 (Forkhead Box P2): FOXP2 is involved in speech and language development and has been associated with language disorders. Its deletion can contribute to language and communication challenges.
NUPL2 (Nucleoporin Like 2): NUPL2 is associated with nucleocytoplasmic transport and may have roles in cellular processes related to gene expression.
CDK6 (Cyclin-Dependent Kinase 6): CDK6 is a cell cycle regulator that plays a role in cell division and proliferation.
CDK13 (Cyclin-Dependent Kinase 13): CDK13 is another member of the cyclin-dependent kinase family and is involved in the regulation of transcription.
METTL10 (Methyltransferase Like 10): This gene is associated with methyltransferase activity and may play a role in RNA processing.
FSCN1 (Fascin Actin-Bundling Protein 1): FSCN1 is involved in the bundling of actin filaments and may play a role in cellular structure and motility.
PAM (Peptidylglycine Alpha-Amidating Monooxygenase): PAM is involved in the amidation of peptide hormones and neurotransmitters.
HMGN2 (High Mobility Group Nucleosomal Binding Domain 2): HMGN2 is associated with nucleosome binding and may play a role in chromatin structure and gene expression regulation.
KMT2E (Lysine Methyltransferase 2E): This gene is involved in histone methylation and may play a role in epigenetic regulation.
CCDC39 (Coiled-Coil Domain Containing 39): CCDC39 is associated with ciliary function and may be involved in ciliopathies and respiratory ciliary function.
NOMO1 (NODAL Modulator 1): NOMO1 is associated with the regulation of NODAL signaling, which plays a role in embryonic development.
AKAP9 (A-Kinase Anchoring Protein 9): AKAP9 is associated with anchoring protein kinase A and may play a role in the regulation of cellular processes.
CALCR (Calcitonin Receptor): CALCR is involved in the regulation of calcium homeostasis and may play a role in bone metabolism.
CUX2 (Cut Like Homeobox 2): CUX2 is associated with neuronal development and may play a role in the development of the cerebral cortex.
GLI3 (GLI Family Zinc Finger 3): GLI3 is involved in the Hedgehog signaling pathway and plays a role in limb development.
SEPT9 (Septin 9): SEPT9 is a member of the septin family and may be involved in cytokinesis and cellular morphology.
METTL21A (Methyltransferase Like 21A): METTL21A is associated with methyltransferase activity and may play a role in RNA processing.
PRSS12 (Serine Protease 12): PRSS12 is associated with serine protease activity and may play a role in protein digestion.
SP4 (Sp4 Transcription Factor): SP4 is a transcription factor involved in the regulation of gene expression and may play a role in neural development.
THSD7B (Thrombospondin Type 1 Domain Containing 7B): THSD7B is associated with thrombospondin type 1 domain and may play a role in vascular development.
VLDLR (Very Low-Density Lipoprotein Receptor): VLDLR is involved in lipoprotein metabolism and may play a role in cholesterol homeostasis.
RNF216 (Ring Finger Protein 216): RNF216 is associated with ubiquitin ligase activity and may be involved in protein degradation.
LOC105371702 (Uncharacterized protein LOC105371702): The function of this protein is currently uncharacterized.
LOC105370121 (Uncharacterized protein LOC105370121): The function of this protein is currently uncharacterized.
LOC105370123 (Uncharacterized protein LOC105370123): The function of this protein is currently uncharacterized.
LOC101929393 (Uncharacterized protein LOC101929393): The function of this protein is currently uncharacterized.
LOC105371873 (Uncharacterized protein LOC105371873): The function of this protein is currently uncharacterized.
HMGN2 (High Mobility Group Nucleosomal Binding Domain 2): HMGN2 is associated with nucleosome binding and may play a role in chromatin structure and gene expression regulation.
KMT2E (Lysine Methyltransferase 2E): This gene is involved in histone methylation and may play a role in epigenetic regulation.
CCDC39 (Coiled-Coil Domain Containing 39): CCDC39 is associated with ciliary function and may be involved in ciliopathies and respiratory ciliary function.
NOMO1 (NODAL Modulator 1): NOMO1 is associated with the regulation of NODAL signaling, which plays a role in embryonic development.
AKAP9 (A-Kinase Anchoring Protein 9): AKAP9 is associated with anchoring protein kinase A and may play a role in the regulation of cellular processes.
CALCR (Calcitonin Receptor): CALCR is involved in the regulation of calcium homeostasis and may play a role in bone metabolism.
CUX2 (Cut Like Homeobox 2): CUX2 is associated with neuronal development and may play a role in the development of the cerebral cortex.
GLI3 (GLI Family Zinc Finger 3): GLI3 is involved in the Hedgehog signaling pathway and plays a role in limb development.
SEPT9 (Septin 9): SEPT9 is a member of the septin family and may be involved in cytokinesis and cellular morphology.
METTL21A (Methyltransferase Like 21A): METTL21A is associated with methyltransferase activity and may play a role in RNA processing.
GLI2 (GLI Family Zinc Finger 2): GLI2 is a transcription factor involved in the Hedgehog signaling pathway and may play a role in various developmental processes.
LOC105371852 (Uncharacterized protein LOC105371852): The function of this protein is currently uncharacterized.LOC105370099 (Uncharacterized protein LOC105370099): The function of this protein is currently uncharacterized.LOC105371940 (Uncharacterized protein LOC105371940): The function of this protein is currently uncharacterized.LOC105371954 (Uncharacterized protein LOC105371954): The function of this protein is currently uncharacterized.LOC105371960 (Uncharacterized protein LOC105371960): The function of this protein is currently uncharacterized.LOC105371970 (Uncharacterized protein LOC105371970): The function of this protein is currently uncharacterized.LOC105371985 (Uncharacterized protein LOC105371985): The function of this protein is currently uncharacterized.LOC105372000 (Uncharacterized protein LOC105372000): The function of this protein is currently uncharacterized.LOC105372004 (Uncharacterized protein LOC105372004): The function of this protein is currently uncharacterized.